NEW YORK, Aug 30 (Reuters) – U.S. regulators said on Tuesday
that AstraZeneca Plc will pay $5.52 million to resolve a
foreign bribery probe into improper payments by its sales and
marketing staff to…
The post AstraZeneca to pay $5.52 mln to resolve U.S. SEC foreign bribery case appeared first on NASDAQ.